The correlations between endogenous dehydroepiandrosterone sulfate and some atherosclerosis risk factors in premenopausal women.
BACKGROUND
Dehydroepiandrosterone (DHEA) is postulated to have antiatherogenic properties, but the possible mechanism of this action is unclear. The aim of this study was to determine the influence of endogenous DHEA-S on the levels of some factors playing significant roles in atherogenesis.


METHODS
In a group of 40 premenopausal women, relationships between endogenous DHEA-S and serum lipids and the apolipoproteins A1 (apoA1) and B (apoB), serum lipid peroxide (LPO), and total antioxidant system (TAS) concentrations as markers of the serum antioxidant-prooxidant balance were measured as well as clinical and biochemical parameters playing roles in atheromatosis such as the type of obesity and the serum glucose, insulin, insulin-like growth factor (IGF-1) and homocysteine (HCY) concentrations.


RESULTS
Statistical analysis revealed significant correlation (p<0.05) between serum DHEA-S level and the serum concentrations of: HDL(2)-C (r=0.53), HDL(2)-C/HDL(3)-C (r=0.58), TG (r=0.35), IGF-1 (r=0.39), and HCY (r=-0.44). There was no statistically significant correlation between DHEA-S level and other biochemical and clinical parameters (age, BMI, WHR) found in this study.


CONCLUSIONS
Despite unfavorable correlation between DHEA-S and TG concentration, the results of this study indicate a potential antiatherogenic action of DHEA which may occur through various mechanisms: by increasing HDL(2)-C and the HDL(2)-C/HDL(3)-C ratio, which has an atheroprotective effect, by elevating the serum IGF-1 concentration, or by decreasing the HCY level. These preliminary results, however, require further investigation.
Bednarek-Tupikowska
Grazyna
G
Department of Endocrinology, Diabetology, and Isotope Treatment, Medical University of Wrocław, Wrocław, Poland. tupikowska@epf.pl
Tworowska-Bardzińska
Urszula
U
Tupikowski
Krzysztof
K
Bohdanowicz-Pawlak
Anna
A
Szymczak
Jadwiga
J
Kubicka
Eliza
E
Skoczyńska
Anna
A
Milewicz
Andrzej
A
D050197:Atherosclerosis / Q000097:blood* / Q000209:etiology*; D001786:Blood Glucose / Q000378:metabolism; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D005260:Female; D006710:Homocysteine / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D017697:Premenopause / Q000097:blood*; D012307:Risk Factors
D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D006710:Homocysteine; D019314:Dehydroepiandrosterone Sulfate; D007334:Insulin-Like Growth Factor I